NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional)
This grant provides funding for multidisciplinary research centers in the U.S. to advance the understanding and treatment of sensory and communication disorders, such as those affecting hearing, speech, and balance.
The National Institute on Deafness and Other Communication Disorders (NIDCD), part of the National Institutes of Health (NIH), has reissued its funding opportunity for the NIDCD Clinical Research Center Grant under activity code P50. This opportunity supports interdisciplinary clinical research centers focused on human sensory and communication disorders. Research may involve individuals directly affected by disorders of hearing, balance, smell, taste, voice, speech, or language, as well as data or tissues derived from them. The mechanism enables applicants to form centers around a unifying research theme, with 3โ4 highly integrated projects supported by an administrative core and optionally, 1โ2 scientific cores. This funding opportunity seeks to foster innovative, synergistic research that offers a comprehensive approach to complex clinical issues. Applications must demonstrate multidisciplinary collaboration and propose a coherent set of interrelated studies addressing a central scientific question. Projects should leverage each otherโs findings and infrastructure to maximize scientific return. The research must primarily focus on individuals with sensory and/or communication disorders, although carefully justified exceptions may be allowed. Centers must include a required Administrative Core, which oversees all operations and acts as the central hub for coordination. Optional Scientific Cores may support shared needs such as data management or specialized technical services, but they must serve multiple research projects. Applications must also outline an External Advisory Committee, whose members, although unnamed at submission, are expected to provide ongoing scientific guidance and performance evaluation. Applicants may propose low-risk clinical trials or basic science experimental studies involving human subjects. High-risk clinical trials or those requiring FDA oversight are excluded. New applications are capped at $1.5 million in direct costs annually. Renewals may request up to 10% more than the final year of the existing award, but not exceeding $2 million annually. The maximum award period is five years. The next available due date is November 4, 2025, with subsequent deadlines in February, June, and October through 2028. Each cycle includes a scientific merit review, advisory council review, and award notice, with an anticipated start approximately eight months after submission. Applications must follow the NIH Multi-Project (M) Application Guide and be submitted via NIH ASSIST or institution-approved system-to-system platforms. For questions, scientific inquiries should be directed to Dr. Holly L. Storkel at holly.storkel@nih.gov, and grants management questions to Samantha Tempchin at samantha.tempchin@nih.gov. This opportunity is open to a broad range of eligible U.S. entities including institutions of higher education, nonprofits, small businesses, and government agencies. Applications with foreign subawards will not be accepted. The funding opportunity will remain active through June 3, 2028.
Award Range
Not specified - $1,500,000
Total Program Funding
Not specified
Number of Awards
Not specified
Matching Requirement
No
Additional Details
New applications capped at $1.5M/year direct costs, renewals capped at $2M or 10% above prior year; maximum project period 5 years
Eligible Applicants
Additional Requirements
Eligibility includes a diverse range of entities as listed directly in the forecast, aiming to foster broad and multidisciplinary collaboration.
Geographic Eligibility
All
Application Opens
Not specified
Application Closes
February 2, 2026
Subscribe to view contact details
